H. D. Smith names Ed Bissler corporate VP sales
SPRINGFIELD, Ill. — H. D. Smith on Thursday named Ed Bissler corporate VP sales. Bissler comes to H. D. Smith from McKesson, where he most recently directed the strategic sales and service functions for many of that company’s national accounts.
In his new role at H. D. Smith, Bissler will be responsible for overseeing the company’s overall sales function and implementing the strategic direction of the sales team as H. D. Smith targets new growth sectors.
“Senior-level sales leadership is more than simply overseeing the day-to-day function of a sales team or landing a large account," stated Chris Smith, H. D. Smith COO. "Sales leadership requires equipping the entire sales organization with the tools and knowledge to pair our solutions with our customers’ challenges. Ed’s proven strategic approach to sales allows him to lead the charge in extending H. D. Smith’s customer-centric values to an increasing number of retail and institutional community pharmacies."
Prior to joining H. D. Smith, Bissler served as VP strategic solutions in retail national accounts at McKesson. In that position, he ensured the retention and customer satisfaction of some of McKesson’s largest pharmacy customers. Before his role in national accounts, Bissler served in positions of increasing responsibility at McKesson, beginning as a hospital account manager and working his way up to a regional manager role.
Bissler earned a bachelor’s degree in marketing from Kent State University. He is trained as a Six Sigma Greenbelt.
Amgen teams up with Blythe Danner for Act 2 Reduce Fractures campaign
THOUSAND OAKS, Calif. — Amgen has launched an educational campaign that targets women with postmenopausal osteoporosis at increased risk for fractures.
The drug maker said that to promote its Act 2 Reduce Fractures campaign, which is supported by American Bone Health, the Global Healthy Living Foundation and the Older Women’s League, the company has tapped award-winning actress Blythe Danner, who was diagnosed with the disease, to encourage women to learn of the risk factors and ways to improve their condition.
"One-in-2 women over age 50 will have an osteoporosis-related fracture in her lifetime," American Bone Health executive director Kathleen Cody said. "And many women don’t proactively work with their doctors to help manage the disease and understand the factors that may increase their risk for fractures. Our goal is to encourage women with postmenopausal osteoporosis at increased risk for fractures to take action and speak to their doctors to learn all they can about helping to strengthen their bones."
Click here for more information.
Hi-Tech’s ECR subsidiary to market two acquired products
AMITYVILLE, N.Y. — Hi-Tech Pharmacal has acquired marketing and distribution rights for a product designed to treat coughs and upper respiratory symptoms associated with an allergy or a cold.
The generic drug maker said it attained rights for TussiCaps, available in 10-mg/8-mg and 5-mg/4-mg formulations, from Mallinckrodt. Hi-Tech’s ECR Pharmaceuticals subsidiary, which markets branded prescription products, will promote TussiCaps, the only extended-release prescription cough-cold capsule product approved by the Food and Drug Administration.
In related news, Hi-Tech also recently acquired the marketing and distribution rights to an abbreviated new drug application filing from KVK-Tech for an antihistamine/decongestant product — dexbrompheniramine maleate 6-mg/pseudoephedrine sulfate 120-mg extended release tablets — which will be marketed by ECR under the brand name Lodrane.